Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection

JAMA Oncol. 2016 Feb;2(2):178-9. doi: 10.1001/jamaoncol.2015.4637.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticarcinogenic Agents / therapeutic use*
  • Erlotinib Hydrochloride / therapeutic use*
  • Female
  • Humans
  • Male
  • Mouth Neoplasms / prevention & control*
  • Precancerous Conditions / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use*

Substances

  • Anticarcinogenic Agents
  • Protein Kinase Inhibitors
  • Erlotinib Hydrochloride